Genetic suppression features ABHD18 as a Barth syndrome therapeutic target.

Masud SN, Srivastava A, Mero P, Echezarreta VS, Anderson E, van Buren L, Wei J, Taylor DT, Farias AG, Mikolajewicz N, Shaw A, Murareanu BM, Lohbihler M, Carney OS, van Heeringen S, Clijsters L, Sizova O, van Ameijde J, Nye F, Habsid A, Nedyalkova L, McDonald L, Simpson C, Wybenga-Groot L, Brown KR, Nho N, Suciu RM, Chan K, Tong AHY, Vaz FM, Evers B, Lesurf R, Papaz T, Nutter LMJ, Protze S, Billmann M, Costanzo M, Andrews BJ, Myers CL, Mital S, Vernon H, Brummelkamp TR, Boone C, Scott IC, Niphakis MJ, Strathdee D, Nijman SMB, Blomen VA, Moffat J

Open source

DOI: 10.1038/s41586-025-09373-5
Published: 2025 Sep
Container: Nature
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41586-025-09373-5,
  title = {Genetic suppression features ABHD18 as a Barth syndrome therapeutic target.},
  author = {Masud SN and Srivastava A and Mero P and Echezarreta VS and Anderson E and van Buren L and Wei J and Taylor DT and Farias AG and Mikolajewicz N and Shaw A and Murareanu BM and Lohbihler M and Carney OS and van Heeringen S and Clijsters L and Sizova O and van Ameijde J and Nye F and Habsid A and Nedyalkova L and McDonald L and Simpson C and Wybenga-Groot L and Brown KR and Nho N and Suciu RM and Chan K and Tong AHY and Vaz FM and Evers B and Lesurf R and Papaz T and Nutter LMJ and Protze S and Billmann M and Costanzo M and Andrews BJ and Myers CL and Mital S and Vernon H and Brummelkamp TR and Boone C and Scott IC and Niphakis MJ and Strathdee D and Nijman SMB and Blomen VA and Moffat J},
  year = {2025},
  journal = {Nature},
  doi = {10.1038/s41586-025-09373-5},
  url = {https://doi.org/10.1038/s41586-025-09373-5}
}

RIS

TY  - JOUR
TI  - Genetic suppression features ABHD18 as a Barth syndrome therapeutic target.
AU  - Masud SN
AU  - Srivastava A
AU  - Mero P
AU  - Echezarreta VS
AU  - Anderson E
AU  - van Buren L
AU  - Wei J
AU  - Taylor DT
AU  - Farias AG
AU  - Mikolajewicz N
AU  - Shaw A
AU  - Murareanu BM
AU  - Lohbihler M
AU  - Carney OS
AU  - van Heeringen S
AU  - Clijsters L
AU  - Sizova O
AU  - van Ameijde J
AU  - Nye F
AU  - Habsid A
AU  - Nedyalkova L
AU  - McDonald L
AU  - Simpson C
AU  - Wybenga-Groot L
AU  - Brown KR
AU  - Nho N
AU  - Suciu RM
AU  - Chan K
AU  - Tong AHY
AU  - Vaz FM
AU  - Evers B
AU  - Lesurf R
AU  - Papaz T
AU  - Nutter LMJ
AU  - Protze S
AU  - Billmann M
AU  - Costanzo M
AU  - Andrews BJ
AU  - Myers CL
AU  - Mital S
AU  - Vernon H
AU  - Brummelkamp TR
AU  - Boone C
AU  - Scott IC
AU  - Niphakis MJ
AU  - Strathdee D
AU  - Nijman SMB
AU  - Blomen VA
AU  - Moffat J
PY  - 2025
JO  - Nature
DO  - 10.1038/s41586-025-09373-5
UR  - https://doi.org/10.1038/s41586-025-09373-5
ER  -

APA

SN, M., A, S., P, M., VS, E., E, A., L, V. B., J, W., DT, T., AG, F., N, M., A, S., BM, M., M, L., OS, C., S, V. H., L, C., O, S., J, V. A., F, N., A, H., L, N., L, M., C, S., L, W., KR, B., N, N., RM, S., K, C., AHY, T., FM, V., B, E., R, L., T, P., LMJ, N., S, P., M, B., M, C., BJ, A., CL, M., S, M., H, V., TR, B., C, B., IC, S., MJ, N., D, S., SMB, N., VA, B., & J, M. (2025). Genetic suppression features ABHD18 as a Barth syndrome therapeutic target.. Nature. https://doi.org/10.1038/s41586-025-09373-5

Source records

pubmed · retrieved 2026-09-26T03:57:59.668Z